Laverock Therapeutics Seed
laverocktx.com
Molecular Diagnostics
Cell & Gene Therapy
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Sep 2026 · this month
Team
51-200
employees, estimated range
Grants
$2M
3 grants · CORDIS
Backers
1
Future Planet Capital
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 30
Raised a round Venture round
Oct 1, 2025
Won a grant $633k · CORDIS
Jul 21, 2025
Raised a round Venture round
Apr 25, 2024
Raised a round Venture round
Oct 9, 2023
Raised a round Venture round
Oct 1, 2023
Won a grant $876k · CORDIS
Sep 1, 2022
Won a grant $444k · CORDIS
Dec 22, 2021
Raised a round Venture round
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Oct 2025 | $633k | — | CORDIS |
| Venture round | Jul 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Apr 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Oct 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Oct 2023 | $876k | — | CORDIS |
| Grant | Sep 2022 | $444k | — | CORDIS |
| Venture round | Dec 2021 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | Laverock Therapeutics Ltd. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Future Planet Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Designer cell therapies for pets first and their people next.
Instant Quantification of genetic modifications for Cell and Gene Therapies.
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
Pioneering Cell Therapies for the Central Nervous System. We are a Salt Lake City-based biotechnology company developing novel macrophage…
Pencil Biosciences is pioneering the next generation of gene editing. We are developing a fully synthetic, RNA-guided platform designed to…
Financials
Total raised
$2M
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds